-
EP3823673
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3823673
| EP3823673 - ANTI-CD112R COMPOSITIONS AND METHODS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 23.04.2021 Database last updated on 22.08.2024 | |
| Former | The international publication has been made Status updated on 25.01.2020 | Most recent event Tooltip | 24.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Surface Oncology, Inc. 50 Hampshire Street 8th Floor Cambridge, MA 02139 / US | [2021/21] | Inventor(s) | 01 /
PRINZ, Bianka 7 Lucent Drive Lebanon, New Hampshire 03766 / US | 02 /
BOLAND, Nadthakarn 7 Lucent Drive Lebanon, New Hampshire 03766 / US | 03 /
SCHUTZ, Kevin 7 Lucent Drive Lebanon, New Hampshire 03766 / US | 04 /
BUKOWSKI, John 7 Lucent Drive Lebanon, New Hampshire 03766 / US | 05 /
SYMONDS, Jennifer 7 Lucent Drive Lebanon, New Hampshire 03766 / US | 06 /
MOHAN, James 50 Hampshire Street, 8th Floor Cambridge, Massachusetts 02139 / US | 07 /
SICHEVA, Marisella Panduro 50 Hampshire Street, 8th Floor Cambridge, Massachusetts 02139 / US | [2021/21] | Representative(s) | Bhogal, Jasber Kaur GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2021/21] | Application number, filing date | 19838134.5 | 19.07.2019 | [2021/21] | WO2019US42545 | Priority number, date | US201862701065P | 20.07.2018 Original published format: US 201862701065 P | US201962844958P | 08.05.2019 Original published format: US 201962844958 P | [2021/21] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020018879 | Date: | 23.01.2020 | Language: | EN | [2020/04] | Type: | A1 Application with search report | No.: | EP3823673 | Date: | 26.05.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.01.2020 takes the place of the publication of the European patent application. | [2021/21] | Search report(s) | International search report - published on: | US | 23.01.2020 | (Supplementary) European search report - dispatched on: | EP | 12.04.2022 | Classification | IPC: | A61K45/06, A61K47/68, C07K16/28, A61K31/7088, A61K39/00, A61P35/00 | [2022/19] | CPC: |
A61P35/00 (EP,IL,KR,US);
C07K16/2818 (EP,IL,US);
C07K16/2896 (KR);
A61K31/7088 (EP,IL);
A61K45/06 (EP,IL,US);
A61P37/04 (US);
C07K16/2803 (EP,IL,KR,US);
C07K16/2827 (IL,US);
A61K2039/505 (EP,IL,KR,US);
A61K2039/507 (EP,IL,US);
A61K2300/00 (IL);
C07K2317/21 (EP,IL,KR);
C07K2317/30 (EP,IL,KR);
C07K2317/52 (US);
C07K2317/622 (EP,IL,KR);
C07K2317/70 (EP,IL,KR);
C07K2317/73 (EP,IL,KR,US);
C07K2317/74 (US);
| C-Set: |
A61K31/7088, A61K2300/00 (EP)
|
| Former IPC [2021/21] | A61K45/06, A61K47/68, C07K16/28 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/21] | Extension states | BA | 01.02.2021 | ME | 01.02.2021 | Validation states | MA | 01.02.2021 | Title | German: | ANTI-CD112R-ZUSAMMENSETZUNGEN UND VERFAHREN | [2021/21] | English: | ANTI-CD112R COMPOSITIONS AND METHODS | [2021/21] | French: | COMPOSITIONS ANTI-CD112R ET PROCÉDÉS | [2021/21] | Entry into regional phase | 01.02.2021 | National basic fee paid | 01.02.2021 | Search fee paid | 01.02.2021 | Designation fee(s) paid | 01.02.2021 | Examination fee paid | Examination procedure | 01.02.2021 | Examination requested [2021/21] | 11.10.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 01.02.2021 | Renewal fee patent year 03 | 21.07.2022 | Renewal fee patent year 04 | 20.07.2023 | Renewal fee patent year 05 | 23.07.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2016134333 (COMPUGEN LTD [IL]); | [I]US2017240613 (ZHU YUWEN [US], et al); | [I]WO2018017864 (ONCOMED PHARM INC [US]); | [I]WO2018033798 (COMPUGEN LTD [IL]); | International search | [A]WO0158459 (MITSUBISHI TOKYO PHARM INC [JP], et al); | [A]WO2007009065 (MACROGENICS INC [US], et al); | [A]WO2010022120 (REGENERON PHARMA [US], et al); | [A]WO2013059524 (UNIV EMORY [US], et al); | [A]US2017088620 (NIOI PAUL [US], et al); | [A]US2017240613 (ZHU YUWEN [US], et al) |